Skip to main content
. 2021 Mar 26;10(9):2967–2977. doi: 10.1002/cam4.3868

TABLE 2.

Baseline and treatment characteristics for patients with meningioma. (n = 2070)

Variable

Meningioma patients

(n = 2070)

Age, median (First quartile(Q1), Third quartile(Q3)) 60 (49, 69)
Female, n (%) 1449, (70.0)
Asymptomatic, n (%) 294 (14.2)
WHO functional status, n (%)
0, fully active 933 (45.1)
1, light work possible 566 (27.3)
2, cares for self 305 (14.7)
3, limited self care 144 (7.0)
4, disabled, confined to bed 20 (1.0)
Missing 102
Tumor laterality, n (%)
Left 736 (35.6)
Right 856 (41.4)
Bilateral 123 (5.9)
Missing 355
Localization, n (%)
Skull‐base 290 (14.0)
Not Skull‐base 1780 (86.0)
Tumor size, n (%)
<4 cm 924 (52.8)
4–6 cm 597 (34.1)
>6 cm 230 (13.1)
Missing 319
Simpson grade, n (%)
Grade I‐III 1587 (86.5)
Grade IV‐V 247 (13.5)
Missing 236
New deficit after surgery, n (%) 310 (15.0)
Missing 4
Reoperation due to complication, n (%) 103 (5.0)
Missing 3
WHO grade, n (%)
Grade I 1803 (87.1)
Grade II‐III 267 (12.9)
Oncological treatment planned, n (%) 120 (5.9)
Missing 27
Wait time from radiological diagnosis (surgery date‐radiological diagnosis), weeks median (Q1,Q3) 10 (4, 24)